Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
Details for Australian Patent Application No. 2004257632 (hide)
International Classifications
Event Publications
19 January 2006 PCT application entered the National Phase
PCT publication WO2005/007132 Priority application(s): WO2005/007132
13 November 2008 Assignment before Grant
Corus Pharma, Inc. The application has been assigned to Gilead Sciences, Inc.
30 July 2009 Application Accepted
Published as AU-B-2004257632
24 December 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 30 Jun 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
15 April 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 30 Jun 2009
22 April 2010 Standard Patent Sealed
27 May 2010 Extension of Term of Standard Patents
Gilead Sciences, Inc. The earliest first regulatory approval date provided by the patentee 04 Feb 2010 For the goods CAYSTON aztreonam
15 July 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 23 Jun 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
12 August 2010 Extension of Term of Standard Patents
Gilead Sciences, Inc. The earliest first regulatory approval date provided by the patentee 04 Feb 2010 For the goods CAYSTON aztreonam Address for service in Australia: Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
2 December 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 23 Jun 2010
23 December 2010 Extension granted
Gilead Sciences, Inc. The earliest first regulatory approval date provided by the patentee 04 Feb 2010 For the goods CAYSTON aztreonam Extension of Term of patent pursuant to Section 77 expires on 04 Feb 2025
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004257636-Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
2004257630-Occluding device for occluding fluid flow through a body vessel
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser